Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple...
Clinical features and disability progression in multiple sclerosis in Tunisia: Do we really have a more aggressive disease course?
Sidhom Y, Damak M, Riahi A, Hizem Y, Mrissa R, Mhiri C, Gouider R.
BACKGROUND: Few epidemiological data are available on multiple sclerosis (MS) patients in North Africa (NA). Studies of immigrants from NA showed...
Leg spasticity and ambulation in multiple sclerosis.
Balantrapu S, Sosnoff JJ, Pula JH, Sandroff BM, Motl RW.
Background. Spasticity of the legs is common in multiple sclerosis (MS), but there has been limited research examining its association with ambulatory outcomes.
Objective. This study examined spasticity of the legs and its...